Sign In
Buy PRVCF
$0.0090
+0 (+0%)
At Close: Jun 03, 2026
PreveCeutical Announces Up-Sized Non-Brokered Private Placement
09:45pm, Monday, 14'th Apr 2025
Vancouver, British Columbia--(Newsfile Corp. - April 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that, further to its news
PreveCeutical Announces Update to Non-Brokered Private Placement
07:04pm, Wednesday, 02'nd Apr 2025
Vancouver, British Columbia--(Newsfile Corp. - April 2, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce a non-broker
PreveCeutical Announces Update to Private Placement
06:00pm, Monday, 10'th Mar 2025
Vancouver, British Columbia--(Newsfile Corp. - March 10, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that further to its news
PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease
07:00am, Thursday, 06'th Feb 2025
Vancouver, British Columbia--(Newsfile Corp. - February 6, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces a program aiming to de
Appointment of Dr. Bryan Jones as an Advisor to Lead Sol-Gel Special Projects
07:00am, Tuesday, 04'th Feb 2025
Vancouver, British Columbia--(Newsfile Corp. - February 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), (the "Company" or "PreveCeutical") a health sciences company that d
PreveCeutical Announces Non-Brokered Private Placement
05:30pm, Friday, 24'th Jan 2025
Vancouver, British Columbia--(Newsfile Corp. - January 24, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce a non-bro
BioGene Therapeutics to Participate in the 43rd JP Morgan Healthcare Conference
12:54pm, Tuesday, 07'th Jan 2025
Vancouver, British Columbia--(Newsfile Corp. - January 7, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that de
PreveCeutical Announces Change of Auditors
04:30pm, Wednesday, 18'th Dec 2024
Vancouver, British Columbia--(Newsfile Corp. - December 18, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that the Company has
BioGene Therapeutics Appoints Patroski J. Lawson to Board of Directors
07:00am, Monday, 09'th Dec 2024
Vancouver, British Columbia--(Newsfile Corp. - December 9, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that de
BioGene Therapeutics Announces Appointment of Dr. Brian Gallagher, Jr. to Corporate Advisory Board
07:00am, Wednesday, 04'th Dec 2024
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that de
BioGene Therapeutics Welcomes Stephen Glover to Its Board of Directors
07:00am, Monday, 02'nd Dec 2024
Vancouver, British Columbia--(Newsfile Corp. - December 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that de
BioGene Therapeutics Welcomes Dr. Deepak Sampath, PhD. to Its Board of Directors
07:00am, Monday, 25'th Nov 2024
Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that d
BioGene Therapeutics Welcomes Professor Mirela Delibegovic, FRSE to Its Scientific Advisory Board
07:00am, Thursday, 21'st Nov 2024
Vancouver, British Columbia--(Newsfile Corp. - November 21, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that d
Vancouver, British Columbia--(Newsfile Corp. - November 18, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that d
PreveCeutical Announces Closing of BioGene Therapeutics Transaction
02:49pm, Friday, 15'th Nov 2024
Vancouver, British Columbia--(Newsfile Corp. - November 15, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that
